Wan, G., Cao, F., Wang, X., & Sun, X. (2019). Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer. J Cancer.
Citação norma ChicagoWan, Guoxing, Fengjun Cao, Xuanbin Wang, and Xue Sun. "Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer." J Cancer 2019.
MLA citiranjeWan, Guoxing, Fengjun Cao, Xuanbin Wang, and Xue Sun. "Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer." J Cancer 2019.
Opozorilo: Ti citati niso vedno 100% točni.